Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 12.6B | 10B | 10.2B | 10.0B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 4.3B | 3.7B | 3.7B | 3.5B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -5.9B | 1.7B | 1.5B | 2.2B |
Tax provision | -1.7B | 325M | 366M | 441M |
Net income | -4.3B | 1.4B | 1.1B | 1.8B |
Basic EPS | -8.6 | 3.5 | 2.7 | 4.4 |
Diluted EPS | -8.6 | 3.5 | 2.7 | 4.4 |
Basic average shares | 505.6M | 383.1M | 382.4M | 383M |
Diluted average shares | 505.6M | 384M | 383.4M | 383.7M |
EBITDA | — | — | — | — |
Net income from continuing op. | -4.3B | 1.4B | 1.1B | 1.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | -2M | 22M | 17M | 28M |